International Scholarly Research Notices / 2011 / Article / Tab 2

Research Article

c-kit and bcl-2 Are Not Useful Markers in Differentiating Adenoid Cystic Carcinoma from Polymorphous Low-Grade Adenocarcinoma

Table 2

Total immunoreactivity of bcl-2 and c-kit observed in ACC and PLGA expressed as number of cases ( 𝑛 ) and as a percentage (%).

Total n of casesACCPLGA
2923

% immunostaining<3030–60>60<3030–60>60%
𝑛 % 𝑛 % 𝑛 % 𝑛 % 𝑛 % 𝑛 %

bcl-2620.726.92172.4417.4626.11356.5
c-kit polyclonal1344.8827.6827.61982.628.728.7
c-kit monoclonal (pilot study)2689.713.426.92295.70014.3

We are committed to sharing findings related to COVID-19 as quickly and safely as possible. Any author submitting a COVID-19 paper should notify us at help@hindawi.com to ensure their research is fast-tracked and made available on a preprint server as soon as possible. We will be providing unlimited waivers of publication charges for accepted articles related to COVID-19. Sign up here as a reviewer to help fast-track new submissions.